Keyword
Quick search:
Content Search
Result Content Research
Result Content Research
1 Gilead and Merck Initiate Phase 2 Study Evaluating an Oral Weekly Combination Regimen of Investigational Lenacapavir and Investigational Islatravir for HIV-1 Treatment in Virologically Suppressed Adults
2 Bringing Balm to Gilead | The Recorder
3 Gilead (GILD) to Report Q3 Earnings: Is a Beat in the Cards?
4 Gilead's Immunomedics CMO jumps to Aadi as the biotech eagerly awaits FDA decision for first drug
5 2005 Pulitzer Prize winner 'Gilead' holds up just as strong today
6 Gilead Sciences to Release Third Quarter 2021 Financial Results on Thursday, October 28, 2021
7 Why Gilead Sciences Investors Shouldn't Give Up on Remdesivir Just Yet
8 Can Merck's Antiviral for COVID Succeed Where Gilead's Failed?
9 Gilead Sciences Inc. stock outperforms market on strong trading day
10 Covid numbers declining at Mount Gilead Schools
11 Gilead Sciences Announces Veklury® Donations to Help Address the Ongoing COVID-19 Crisis in Indonesia and Armenia
12 ARCH-backed SciNeuro kicks off search for CNS autoantibodies with new deal; Merck + Gilead announce PhII trial for HIV combo
13 Gilead Presents Long-Term Switch Data Reinforcing Biktarvy® as a Treatment Option for a Broad Range of People Living With HIV
14 Gilead Sciences considered Atlanta before selecting Raleigh for 275-job expansion
15 UnitedHealth Enters Antitrust Fray Over Gilead's HIV Drugs (1)
16 Gilead Sciences, Inc. (GILD) Stock Gains 2.72% This Week: Is It a Good Pick?
17 Gilead wins approval of CAR-T therapy in adult leukemia
18 Gilead Launches Pharmaceutical Education Program to Increase Workplace Diversity
19 Gilead: Whither Remdesivir?
20 Handmaid’s Tale: How Bad Is The World’s Population Crisis (Outside Gilead)?
21 Gilead Sciences Inc. stock underperforms Friday when compared to competitors
22 Doris Hildebrand Obituary (1930
23 FDA OKs Gilead's Pediatric HIV Treatment and Boehringer's Humira Biosimilar
24 Gilead, Bristol Myers face lawsuit from major pharmacies over HIV generic drug delays
25 Gilead Sciences Inc. stock rises Thursday, still underperforms market
26 Why Gilead Is The Best Value Stock In Pharma
27 Sanofi poaches Gilead cancer exec Fantin to run its oncology research
28 EMA advisory panel recommends approval of Gilead's Trodelvy for breast cancer
29 Gilead Sciences (GILD) Gains As Market Dips: What You Should Know
30 Gilead and Kite nab another approval for Tecartus, as leading CAR-T portfolio continues to grow
31 FDA Action Alert: Mirum and Kite/Gilead
32 Gilead Sciences Inc. stock underperforms Wednesday when compared to competitors
33 Archaeologists find rare 2,000-year-old ‘Balm of Gilead’ gemstone seal near Western Wall
34 Hampton U Mobile Clinic to host COVID-19 vaccine clinic at Mt. Gilead Baptist Church on Oct. 30
35 Gilead Files for FDA Approval of Second-Line Yescarta for Large B-Cell Lymphoma
36 Rare biblical 'Balm of Gilead' engraving found on 2000-year-old seal in Jerusalem
37 Archaeologists Find Rare 'Balm of Gilead' Gemstone Near Jerusalem's Western Wall
38 Gem Depicting Balm of Gilead and Incense Burned in Before the Holy of Holies Discovered in Jerusalem
39 In Brief This Week: Gilead, Iovance, Eli Lilly, Merck KGaA, GlaxoSmithKline, Aspira Women's Health
40 Gilead Suit Advances Alleging It Delayed Safer HIV Drugs
41 Gilead Sciences Inc. stock rises Wednesday, still underperforms market
42 Alcoholic Hepatitis Therapeutics Market to Witness Rapid Growth by 2028 | Gilead Sciences, Inc., Sanofi, Generon Pharmaceutical Technology (Shanghai) Co., Ltd
43 Hedge Funds Never Been Less Bullish On Gilead Sciences, Inc. (GILD)
44 Gilead Sciences Inc. stock underperforms Tuesday when compared to competitors
45 Federal jury hits Cromwell with $5 million in punitive damages for blocking operation of a group home for men with mental illnesses
46 Gilead Marks Fifth Approval for Trodelvy® in Metastatic Triple-Negative Breast Cancer Under Project Orbis Initiative with Health Canada Authorization
47 Merck's experimental HIV drug islatravir hits with a PhIII combo win and FDA filing plans
48 Wednesday’s Top Analyst Upgrades and Downgrades: Anheuser-Busch, Gilead Sciences, Intuitive Surgical, Micron Technology, Netflix, Urban Outfitters and More
49 200 Mt. Gilead-Improve Water Association customers on boil-water notice
50 Is Gilead Sciences, Inc. (GILD) Stock Worth a Buy Monday?
51 Mount Gilead's McGill, Snopik earn KMAC gold on home course
52 Council members call for Cromwell town manager to resign after $5M verdict
53 Mount Gilead's square beautification in the works
54 Archaeologists Discover 2,000-Year-Old Gemstone with 'Balm of Gilead' Engraving Near Jerusalem's Western Wall
55 MG girls edged by Amanda Saturday
56 2 High-Yielding Stocks You Can Buy and Hold for Years
57 Biotechnology Market Trend Analysis 2021-2025: AstraZeneca, , Gilead Sciences, Inc. , , CELGENE CORPORATION, , Biogen, , Abbott, , Amgen Inc., , Novo Nordisk A/S, , Merck & Co., , Johnson & Johnson Services, Inc. – Puck77
58 LEE COLLINS | Obituaries | montgomeryherald.com
59 Atlanta City Council honors Lil Nas X with his own day at homecoming event
60 Cromwell councilmen rescind letter calling for town manager’s resignation
61 Liver Fibrosis Drug Market Seeking Excellent Growth | Gilead, Biogen Idec, Merck KGaA, Bristol-Myers Squibb Company, Roche, Merck & Co. – Puck77
62 Biotechnology Market Share by 2025 | AstraZeneca,,Gilead Sciences, Inc. ,,CELGENE CORPORATION,,Biogen,,Abbott,,Amgen Inc.,,Novo Nordisk A/S,,Merck & Co. – Puck77
63 Cardington, MG earn XC district titles
64 Global Liver Fibrosis Drug Market 2021 Present Scenario of Manufacturers – Gilead, Bristol-Myers Squibb Company, Biogen Idec, Tri-Prime – IMIESA
65 Unforeseen Drivers Contributing to Liposomes Drug Delivery Market by SpA, Gilead Sciences, Novartis, Spectrum Pharmaceuticals, Enzon – Puck77
66 Trouble builds for Merck's $11.5B Acceleron buy as activist investor behind Gilead's Immunomedics deal says too early, too cheap
67 Autoimmune Hepatitis Treatment Market Growth Drivers, Trends, and analysis by 2028 | Gilead Sciences, Inc., CymaBay Therapeutics, Acorda Therapeutics – Puck77
68 Biotechnology Market Analysis 2025: AstraZeneca, , Gilead Sciences, Inc. , , CELGENE CORPORATION, , Biogen, , Abbott, , Amgen Inc., , Novo Nordisk A/S, , Merck & Co., , Johnson & Johnson Services, Inc. – Puck77
69 Gilead Sciences wins reversal of $1.2 bln award in patent case with Bristol Myers
70 Gilead's slumping COVID-19 drug takes another hit with study showing no real benefit
71 Cutaneous Leishmaniasis Drugs Market 2021-2026 Size and Share, Recent Enhancements and Regional Analysis | Key Companies: GlaxoSmithKline, Novartis, Sanofi, Gilead Sciences, Bristol-Myers Squibb, A… – Puck77
72 Gilead says aware of counterfeit HIV medicines being distributed in U.S.
73 Gilead's COVID-19 drug helps boost 2nd-quarter results as HIV sales dip
74 Gilead, Merck and others slapped with 'pay-for-delay' lawsuits over lucrative HIV and cholesterol meds
75 European Medicines Agency Validates Gilead's Marketing Authorization Application for Lenacapavir, an Investigational, Long-Acting Capsid Inhibitor for the Treatment of HIV-1 in People With Limited Therapy Options
76 Liposomes Drug Delivery Market 2021 Global Outlook, Research, Trends and Forecast to 2028 | SpA, Gilead Sciences, Novartis, Spectrum Pharmaceuticals, Enzon, Teva Pharmaceutical, Pacira, Novavax – Puck77
77 Should You Buy Gilead Stock At $65?
78 Gilead HIV, hepatitis C sales dip, shares down 2.6%
79 Anti-Infective Drugs Market Size and Forecast 2028 | Key Companies – Gilead Sciences GlaxoSmithKline plc, Pfizer Novartis AG, Merck, Bayer AG, Others., – The Manomet Current
80 Gilead to Pay Investors $1.8 Million in Fees Over Truvada Files
81 Remdesivir Averts Hospitalization in Study of High-Risk Patients
82 IAS: En route to FDA decision, Gilead's long-acting drug keeps HIV down in patients 'at the end of options'
83 Gilead's Veklury shows 'no antiviral effects,' small WHO study says as company stands by COVID med
84 Global Hepatitis C Drugs Market 2021 Financial Insights, Business Growth Strategies, Trends | Market Players: Gilead sciences, Abbvi, Johnson & Johnson, Merck, Glaxosmithkline, Novartis, Bristol-My… – Puck77
85 Gilead to Present Latest Antiviral Research Data Addressing Urgent Global Needs in Infectious Disease at IDWeek 2021
86 Gilead Sciences considered Durham before picking Raleigh for 275-job expansion
87 Should You Buy Gilead Sciences in April?
88 Gilead Sciences Endows Its Foundation With More Than $200 Million to Support Health Justice, Community Giving and Employee Match Program
89 CVS, Rite Aid sue Gilead, Bristol-Myers Squibb, Teva for allegedly blocking lower-cost generic HIV drugs
90 Could Moderna Take Down Gilead Sciences?
91 Gilead Sciences Q2 Revenues Grow 21 Percent as CAR T-Cell Business Jumps 39 Percent
92 Gilead faces pressure to lower the price of a drug to treat rare infection
93 Gilead Sciences Announces Steps to Expand Availability of Remdesivir in India
94 Gilead: 'Cell therapy at early stages of penetration'
95 Construction and Demolition Robots Consumption Market Share, End-User, Global Innovations Outlook to 2028 | Johnson & Johnson, Gilead Sciences, Pacira, Sun Pharmaceutical – Puck77
96 Gilead to require U.S. workers receive COVID-19 vaccine
97 Change to Gilead assistance program threatens PrEP access, HIV advocates say
98 NC Fought Hard for Gilead's New Site, Adding to Exploding Biotech Presence
99 Intentionally Delayed Pharmaceutical Innovation Under Perverse Incentives: Gilead's HIV Pipeline As A Case Study
100 The heat is on Gilead as Tropics readout nears